[REGN] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 175.46%
YoY- 92.01%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 1,927,800 1,663,496 1,608,022 1,511,485 1,582,447 1,500,673 1,470,116 19.74%
PBT 676,200 635,861 656,074 585,398 554,767 565,605 525,850 18.19%
Tax -144,200 41,206 104,662 107,418 381,248 177,288 138,106 -
NP 820,400 594,655 551,412 477,980 173,519 388,317 387,744 64.58%
Tax Rate 21.33% -6.48% -15.95% -18.35% -68.72% -31.34% -26.26% -
Total Cost 1,107,400 1,068,841 1,056,610 1,033,505 1,408,928 1,112,356 1,082,372 1.53%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 42.56 35.75 34.29 31.62 10.97 25.88 26.38 37.43%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS 7.58 5.51 5.12 4.44 1.62 3.64 3.66 62.26%
EPS Diluted 7.15 5.17 4.82 4.16 1.49 3.32 3.34 65.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.